Posted Feb. 21, 2014 at 11:37 a.m.

Premium Lock GSK lung drug Anoro recommended for European approval

Published: 2014-02-21 11:37:35
Updated: 2014-02-21 11:37:35

Lung disease Lung disease Image 1 of 2 · Next Image…

Anoro may help GSK protect its respiratory business, which made up 42 percent of its total pharmaceutical sales last year. The company's top-selling product, Advair for smokers' cough and asthma, is facing increasing competition from a newly approved generic in Europe and cheaper options in the U.S....

Read More
Read More

WRAL TechWire any time: Twitter, Facebook

Copyright 2017 WRAL TechWire. All rights reserved.
Editor's Blog

Editor's Blog

The latest blog posts from our WRAL TechWire and WRAL editors. Read more articles…

Please Log In to add a comment.

Latest for Insiders